Physiologically Based Pharmacokinetic (PBPK) Models for Nasal Tissue Dosimetry of Organic Esters: Assessing the State-of-Knowledge and Risk Assessment Applications with Methyl Methacrylate and Vinyl Acetate

By Andersen M.E.   Green T.   Frederick C.B.   Bogdanffy M.S.  

Regulatory Toxicology and Pharmacology, Vol. 36, Iss. 3, 2002-12 ,pp. : 234-245

Academic Press

Access to resources Recommend Favorite

Physiologically Based Pharmacokinetic Models: Integration of In Silico Approaches with Micro Cell Culture Analogues

By  

Current Drug Metabolism, Vol. 13, Iss. 6, 2012-07 ,pp. : 863-880

Bentham Science Publishers

Access to resources Recommend Favorite

Have physiologically-based pharmacokinetic models delivered?

By Edginton Andrea N   Joshi Ghanashyam  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 8, 2011-08 ,pp. : 929-934

Informa Healthcare

Access to resources Recommend Favorite

Structural Identifiability of Physiologically Based Pharmacokinetic Models

By Yates James  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 33, Iss. 4, 2006-08 ,pp. : 421-439

Springer Publishing Company

Access to resources Recommend Favorite

The use of in vitro metabolic parameters and physiologically based pharmacokinetic (PBPK) modeling to explore the risk assessment of trichloroethylene

By Hissink E.M.   Bogaards J.J.P.   Freidig A.P.   Commandeur J.N.M.   Vermeulen N.P.E.   van Bladeren P.J.  

Environmental Toxicology and Pharmacology, Vol. 11, Iss. 3, 2002-07 ,pp. : 259-271

Elsevier

Access to resources Recommend Favorite